The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Intellectual capital and corporate performance in Indian pharmaceutical industry
Abstract
Purpose: The purpose of this paper is to study the relationship, if any, between the intellectual capital (IC) components, namely human, structural, and physical capitals with the traditional measures of performance of the company, namely profitability, productivity and market valuation. Design/methodology/approach: Value added by IC (VAIC™) for top 25 firms in the drug and pharmaceutical industry in India, for a ten‐year period from 1996 to 2006 is estimated. The evaluation is done on the basis of the ranking obtained by each firm in the VAIC index estimated. The analysis of correlation and simple linear multiple regression is done for the set of variables representing the performance of the firm and IC. Findings: The domestic firms seem to be performing well and efficiently utilizing their IC as seen by the VAIC rankings. The empirical analysis found that the human capital was the one which was seen to have the major impact on the profitability and productivity of the firms over the period of study. Though there is a growing importance and efficiency in the utilization of the intellectual resources in the Indian pharmaceutical industry, the reflection of the same in creating an impact on the financial performance of the industry is seen to be missing in the empirical analysis. Research limitations/implications: The results suggest that in Indian scenario, the market is under developed and yet to reflect the performance of the firms especially in terms of the efficiency parameters and more so in terms of IC efficiency. The stakeholders still perceive the performance of the firm in terms of tangible assets and less in terms of intangible assets. This opens up vistas for further exploration of the findings to prove/disprove the same in other industries. Practical implications: The paper has strong theoretical foundations, which have a proven record and applications. The methodology adopted has been research tested. There is an urgent and immediate need that the policy makers and corporate decision makers wake up to the need and start taking up the voluntary disclosures of IC, so that the perception among the stakeholders regarding value creation in the firm may get even more transparent. Originality/value: This is one of the pioneering and seminal attempts to evaluate the IC and its relationship with the traditional measures of corporate performance in Indian pharmaceutical industry. This paper adds to the existing literature, provides a new dimension of performance measurement for knowledge industries in emerging economies and would evoke further research interests to explore different aspects of IC management and measurement in these economies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intellectual capital: The new wealth of organizations
Stewart, T., & Ruckdeschel, C. (1998) · Performance Improvement · doi:10.1002/pfi.4140370713 · Cited by 3,749
Intellectual capital: an exploratory study that develops measures and models
Bontis, N. (1998) · Management Decision · doi:10.1108/00251749810204142 · Cited by 3,276
Assessing knowledge assets: a review of the models used to measure intellectual capital
Bontis, N. (2001) · International Journal of Management Reviews · doi:10.1111/1468-2370.00053 · Cited by 1,689
Intellectual capital and traditional measures of corporate performance
Firer, S., & Mitchell Williams, S. (2003) · Journal of Intellectual Capital · doi:10.1108/14691930310487806 · Cited by 1,111
Developing intellectual capital at Skandia
Edvinsson, L. (1997) · Long Range Planning · doi:10.1016/s0024-6301(97)90248-x · Cited by 917
Bontis, N., Dragonetti, N. C., Jacobsen, K., & Roos, G. (1999) · European Management Journal · doi:10.1016/s0263-2373(99)00019-5 · Cited by 905
Developing intellectual capital at Skandia
Edvinsson, L. (1997) · Long Range Planning · doi:10.1016/s0024-6301(97)00016-2 · Cited by 875
The problem of unobservables in strategic management research
Godfrey, P. C., & Hill, C. W. L. (1995) · Strategic Management Journal · doi:10.1002/smj.4250160703 · Cited by 645
Measuring the performance of intellectual potential in the knowledge economy
Pulić, A. (1998) · Cited by 629
Is intellectual capital performance and disclosure practices related?
Mitchell Williams, S. (2001) · Journal of Intellectual Capital · doi:10.1108/14691930110399932 · Cited by 439
Cited by
Intellectual capital and financial performance: A study of the Turkish Banking Sector
Ozkan, N., Cakan, S., & Kayacan, M. (2017) · Borsa Istanbul Review · doi:10.1016/j.bir.2016.03.001 · Cited by 419
Intellectual capital and financial performance: an evaluation of the Australian financial sector
Joshi, M., Cahill, D., Sidhu, J., & Kansal, M. (2013) · Journal of Intellectual Capital · doi:10.1108/14691931311323887 · Cited by 345
Intellectual capital and firm performance: an extended VAIC model
Bayraktaroglu, A. E., Calisir, F., & Baskak, M. (2019) · Journal of Intellectual Capital · doi:10.1108/jic-12-2017-0184 · Cited by 324
The impact of intellectual capital on firm performance: a study of Indian firms listed in COSPI
Smriti, N., & Das, N. (2018) · Journal of Intellectual Capital · doi:10.1108/jic-11-2017-0156 · Cited by 309
Nadeem, M., Gan, C., & Nguyen, C. (2017) · Measuring Business Excellence · doi:10.1108/mbe-12-2015-0055 · Cited by 140
Metadata
- Authors
- Bharathi Kamath, G.
- Venue
- Journal of Intellectual Capital
- Publisher
- Emerald
- Published
- 2008-10-17
- Volume
- 9
- Issue
- 4
- Pages
- 684-704
- ISSN
- 1469-1930 (ISSN-L)
- OpenAlex
- W2039085346
- Cited by
- 333
- References
- 14
- FWCI
- 25.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intellectual capital and corporate performance in Indian pharmaceutical industry. https://app.cochat.ai/papers/10.1108/14691930810913221
- The paper
- Bharathi Kamath, G. (2008). Intellectual capital and corporate performance in Indian pharmaceutical industry. Journal of Intellectual Capital. https://doi.org/10.1108/14691930810913221
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.